Mode
Text Size
Log in / Sign up

Systematic review finds CCTA underestimates SYNTAX scores versus invasive angiography in coronary artery disease

Systematic review finds CCTA underestimates SYNTAX scores versus invasive angiography in coronary…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider caution when using CCTA-derived SYNTAX scores for borderline coronary artery disease cases.

This systematic review and meta-analysis assessed the agreement between coronary CT angiography (CCTA) and invasive coronary angiography (ICA) for SYNTAX score calculation in adult populations with coronary artery disease. The setting was not reported for the included studies. The primary outcome measured the pooled standardized mean difference in SYNTAX scores between the two modalities using Hedges' g.

The analysis included over 1,800 patients. Results showed a statistically significant underestimation of SYNTAX scores by CCTA compared to ICA. The effect size was Hedges' g = -0.121 with a 95% CI of -0.185 to -0.056 and a p value less than 0.01. No adverse events or discontinuations were reported in the source data.

The authors noted that discrepancies between modalities remain uncertain. Meaningful discrepancies in SYNTAX classification near critical decision thresholds of 22 and 32 were identified as a limitation. Funding or conflicts of interest were not reported. The certainty of the findings is constrained by these uncertainties.

Practice relevance suggests clinicians should interpret CCTA-derived SYNTAX scores with caution. This is particularly important in borderline cases where therapeutic strategies may differ based on the score. The review does not provide specific dosing or safety data beyond the lack of reported adverse events.

Study Details

Study typeMeta analysis
Sample sizen = 1,800
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Accurate assessment of coronary lesion complexity is essential for guiding revascularization strategies in patients with coronary artery disease. The SYNTAX score, originally derived from invasive coronary angiography (ICA), plays a key role in clinical decision-making. With advancements in cardiac computed tomography angiography (CCTA), its potential as a non-invasive tool for SYNTAX scoring has gained interest, but discrepancies between modalities remain uncertain. To systematically compare SYNTAX scores obtained by CCTA versus ICA and evaluate their concordance, with implications for clinical decision-making. We conducted a systematic review and meta-analysis of studies published between 2013 and 2024 comparing SYNTAX scores derived from CCTA and ICA in the same adult populations. Databases including PubMed, Embase, Scopus, Web of Science, and Cochrane Library were searched through January 2025. The primary outcome was the pooled standardized mean difference (Hedges' g) in SYNTAX scores between modalities. Risk of bias was assessed using QUADAS-2, and meta-regression explored potential sources of heterogeneity. Thirteen studies with a total of over 1,800 patients met inclusion criteria. The pooled analysis demonstrated a statistically significant underestimation of SYNTAX scores by CCTA compared to ICA (Hedges' g = - 0.121; 95% CI: -0.185 to - 0.056; p < 0.01). Heterogeneity was moderate (I² = 30.7%) after exclusion of one outlier. Meta-regression revealed no significant impact of publication year, scanner generation, or sample size on effect size. Several studies highlighted meaningful discrepancies in SYNTAX classification near critical decision thresholds (22 and 32). Funnel plot symmetry and Q-Q plot normality suggested minimal publication bias. CCTA systematically underestimates SYNTAX scores compared to ICA, which may impact treatment decisions in patients with complex coronary artery disease. While CCTA offers a promising non-invasive alternative, clinicians should interpret CCTA-derived SYNTAX scores with caution-particularly in borderline cases where therapeutic strategies may differ. Further standardization of scoring protocols and incorporation of functional imaging tools such as CT-FFR are warranted.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.